Evidence map›Paper›PMID 32927835›Full record

ArticleJournal of clinical medicine2020

Profile of Patients with Novel Coronavirus Disease 2019 (COVID-19) in Osaka Prefecture, Japan: A Population-Based Descriptive Study.

Taro Takeuchi, Tomoka Imanaka, Yusuke Katayama, Tetsuhisa Kitamura, Tomotaka Sobue, Takeshi Shimazu

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Factors Associated with Delayed Diagnosis among Patients with COVID-19 in Okinawa, Japan.International journal of environmental research and public health · 2022
    Article
  4. Article
  5. Characteristics and Outcomes of COVID-19 in Reproductive-Aged Pregnant and Nonpregnant Women in Osaka, Japan.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Characteristics and Outcomes of Pediatric COVID-19 Patients in Osaka, Japan.International journal of environmental research and public health · 2021
    Observational
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Taro TakeuchiDepartment of Social Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.ORCID 0000-0002-9900-9608
Tomoka ImanakaDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.
Yusuke KatayamaDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.ORCID 0000-0003-2585-4259
Tetsuhisa KitamuraDepartment of Social Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.
Tomotaka SobueDepartment of Social Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.ORCID 0000-0003-2817-3483
Takeshi ShimazuDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little is known about the epidemiological characteristics of patients with coronavirus disease 2019 (COVID-19) in Japan. This is a retrospective observational study of COVID-19 patients; study was conducted from February 1 to May 31, 2020. We used publicly collected data on cases of COVID-19 confirmed by polymerase chain reaction (PCR) testing in Osaka Prefecture, Japan. We described the patient characteristics. The Cox proportional-hazards model was applied to evaluate the association between factors (sex, onset month, age group, city of residence) and mortality, and hazard ratios (HRs) with 95% confidence intervals were estimated. During the study period, 5.7% (1782/31,152) of individuals who underwent PCR testing for COVID-19 showed positive results. Among 244 patients with information on symptoms, the most common symptom was fever (76.6%), followed by cough (44.3%). Of the 1782 patients, 86 patients died. Compared with those aged 0-59 years, higher mortality was observed among those aged 60-69 years (HR: 12.02 [3.37-42.93]), 70-79 years (HR: 44.62 [15.16-131.30]), 80-89 years (HR: 68.38 [22.93-203.89]), and ≥90 years (HR: 144.71 [42.55-492.15]). In conclusion, in Osaka Prefecture, Japan, the most common symptom was fever, and older adults had higher mortality among COVID-19 patients.

Indexed as

COVID-19elderlyepidemiologyJapanPCR testing

Identifiers

PMID32927835
PMCPMC7564471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.